New oral nanomedicine boosts effectiveness of cancer immunotherapies

Immune checkpoint blockade is a form of cancer treatment that works by releasing the natural brakes on the immune system, allowing T cells to find and destroy cancer cells. Although it has transformed cancer immunotherapy, patients usually have low response rates. In a new study published in Nature Nanotechnology, University of Michigan researchers developed an oral drug that can increase T cells' ability to attack tumors.